Companie

Cadila Healthcare seeks regulatory approval for Covid-19 drug

Reuters BENGALURU | Updated on April 05, 2021

Cadila Healthcare Ltd said on Monday it would seek local regulatory approval to treat Covid-19 patients with an already approved Hepatitis C drug, following promising interim results from a late-stage trial.

Published on April 05, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Covid-1
Cadila Healthcare Ltd
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.